204 related articles for article (PubMed ID: 36061599)
21. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
[TBL] [Abstract][Full Text] [Related]
22. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
[TBL] [Abstract][Full Text] [Related]
23. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.
Liu T; Woo JA; Bukhari MZ; Wang X; Yan Y; Buosi SC; Ermekbaeva A; Sista A; Kotsiviras P; LePochat P; Chacko A; Zhao X; Kang DE
Acta Neuropathol Commun; 2022 Jul; 10(1):95. PubMed ID: 35787294
[TBL] [Abstract][Full Text] [Related]
24. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
[TBL] [Abstract][Full Text] [Related]
25. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
[TBL] [Abstract][Full Text] [Related]
26. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.
Perrone F; Nguyen HP; Van Mossevelde S; Moisse M; Sieben A; Santens P; De Bleecker J; Vandenbulcke M; Engelborghs S; Baets J; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Martin JJ; Van Damme P; Van Broeckhoven C; van der Zee J;
Neurobiol Aging; 2017 Mar; 51():177.e9-177.e16. PubMed ID: 28069311
[TBL] [Abstract][Full Text] [Related]
27. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.
Genin EC; Plutino M; Bannwarth S; Villa E; Cisneros-Barroso E; Roy M; Ortega-Vila B; Fragaki K; Lespinasse F; Pinero-Martos E; Augé G; Moore D; Burté F; Lacas-Gervais S; Kageyama Y; Itoh K; Yu-Wai-Man P; Sesaki H; Ricci JE; Vives-Bauza C; Paquis-Flucklinger V
EMBO Mol Med; 2016 Jan; 8(1):58-72. PubMed ID: 26666268
[TBL] [Abstract][Full Text] [Related]
28. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
[TBL] [Abstract][Full Text] [Related]
29. Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.
Nguyen MK; McAvoy K; Liao SC; Doric Z; Lo I; Li H; Manfredi G; Nakamura K
Hum Mol Genet; 2022 May; 31(9):1500-1518. PubMed ID: 34791217
[TBL] [Abstract][Full Text] [Related]
30. CHCHD10
Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
[TBL] [Abstract][Full Text] [Related]
31. Neuropathologic description of
Keith JL; Swinkin E; Gao A; Alminawi S; Zhang M; McGoldrick P; McKeever P; Robertson J; Rogaeva E; Zinman L
Neurol Genet; 2020 Feb; 6(1):e394. PubMed ID: 32042922
[TBL] [Abstract][Full Text] [Related]
32. Identification of CHCHD2 mutations in patients with Alzheimer's disease, amyotrophic lateral sclerosis and frontotemporal dementia in China.
Liu X; Jiao B; Zhang W; Xiao T; Hou L; Pan C; Tang B; Shen L
Mol Med Rep; 2018 Jul; 18(1):461-466. PubMed ID: 29749507
[TBL] [Abstract][Full Text] [Related]
33. The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction.
Purandare N; Somayajulu M; Hüttemann M; Grossman LI; Aras S
J Biol Chem; 2018 Apr; 293(17):6517-6529. PubMed ID: 29540477
[TBL] [Abstract][Full Text] [Related]
34. Structures of the Wild-Type and S59L Mutant CHCHD10 Proteins Important in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
ACS Chem Neurosci; 2022 Apr; 13(8):1273-1280. PubMed ID: 35349255
[TBL] [Abstract][Full Text] [Related]
35. Targeting ER-Mitochondria Signaling as a Therapeutic Target for Frontotemporal Dementia and Related Amyotrophic Lateral Sclerosis.
Martín-Guerrero SM; Markovinovic A; Mórotz GM; Salam S; Noble W; Miller CCJ
Front Cell Dev Biol; 2022; 10():915931. PubMed ID: 35693938
[TBL] [Abstract][Full Text] [Related]
36. TDP-43 and PINK1 mediate CHCHD10
Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of CHCHD2 may Contribute to Parkinson's Disease by Reducing Expression of NFE2L2 and RQCD1.
Li K; Ning P; Liu B; Yang H; Zhu Y; Yin W; Zhou C; Ren H; Yang X
Curr Neurovasc Res; 2022; 19(1):19-29. PubMed ID: 35388756
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of CHCHD2 in Chinese patients with multiple system atrophy and amyotrophic lateral sclerosis.
Yang X; An R; Zhao Q; Zheng J; Tian S; Chen Y; Xu Y
J Neurol Sci; 2016 Sep; 368():389-91. PubMed ID: 27538669
[TBL] [Abstract][Full Text] [Related]
39. Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients.
Teyssou E; Chartier L; Albert M; Bouscary A; Antoine JC; Camdessanché JP; Rotolo F; Couratier P; Salachas F; Seilhean D; Millecamps S
Neurobiol Aging; 2016 Jun; 42():218.e1-3. PubMed ID: 27095681
[TBL] [Abstract][Full Text] [Related]
40. Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1.
Liu W; Duan X; Xu L; Shang W; Zhao J; Wang L; Li JC; Chen CH; Liu JP; Tong C
Cell Death Differ; 2020 Jun; 27(6):2014-2029. PubMed ID: 31907391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
